Shareholders Equity: The sum of preferred and common equity items.
Beam Therapeutics Inc. (BEAM) had Shareholders Equity of $1.24B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$139.74M |
|
$-79.99M |
|
-- |
|
$139.74M |
|
$523.44M |
|
$-383.69M |
|
$303.70M |
|
$-79.99M |
|
$-79.99M |
|
$-79.99M |
|
$-79.99M |
|
$-79.99M |
|
$-79.99M |
|
$-383.69M |
|
$-377.36M |
|
98.91M |
|
98.91M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$1.27B |
|
$104.50M |
|
$212.49M |
|
$1.48B |
|
$96.94M |
|
-- |
|
$145.88M |
|
$242.82M |
|
$1.24B |
|
$1.24B |
|
|
Shareholders Equity |
$1.24B |
101.75M |
|
| Cash Flow Statement Financials | |
$-345.10M |
|
$-121.44M |
|
$478.05M |
|
$290.11M |
|
$301.62M |
|
$11.51M |
|
$94.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-274.57% |
|
-274.57% |
|
-270.04% |
|
-57.24% |
|
-57.24% |
|
$-360.05M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-6.46% |
|
-6.46% |
|
-5.40% |
|
-6.46% |
|
$12.17 |
|
$-3.64 |
|
$-3.49 |
|